Page 21 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
Single-cell RNA-seq in malignant skin tumors

doi: 10.1016/j.ejcsup.2013.07.012 1366-1379.
46. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, doi: 10.1080/15384047.2019.1640032
Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science.
2013;339(6127):1546-1558. 57. Timar J, Ladanyi A. Molecular pathology of skin melanoma:
Epidemiology, differential diagnostics, prognosis and
doi: 10.1126/science.1235122 therapy prediction. Int J Mol Sci. 2022;23(10):5384.
47. Dahl C, Guldberg P. The genome and epigenome of doi: 10.3390/ijms23105384
malignant melanoma. APMIS. 2007;115(10):1161-1176.
58. Gosman LM, Tapoi DA, Costache M. Cutaneous
doi: 10.1111/j.1600-0463.2007.apm_855.xml.x melanoma: A review of multifactorial pathogenesis,
48. Scolyer RA, Long GV, Thompson JF. Evolving concepts immunohistochemistry, and emerging biomarkers for early
in melanoma classification and their relevance to detection and management. Int J Mol Sci. 2023;24(21):15881.
multidisciplinary melanoma patient care. Mol Oncol. doi: 10.3390/ijms242115881
2011;5(2):124-136.
59. Buja A, Rugge M, Damiani G, et al. Sex differences in
doi: 10.1016/j.molonc.2011.03.002 cutaneous melanoma: Incidence, clinicopathological
49. Loria D, Matos E. Risk factors for cutaneous melanoma: profile, survival, and costs. J Womens Health (Larchmt).
A case-control study in Argentina. Int J Dermatol. 2022;31(7):1012-1019.
2001;40(2):108-114. doi: 10.1089/jwh.2021.0223
doi: 10.1046/j.1365-4362.2001.01132.x 60. Pandiani C, Beranger GE, Leclerc J, Ballotti R, Bertolotto C.
50. Damsky WE, Bosenberg M. Melanocytic nevi and Focus on cutaneous and uveal melanoma specificities. Genes
melanoma: Unraveling a complex relationship. Oncogene. Dev. 2017;31(8):724-743.
2017;36(42):5771-5792. doi: 10.1101/gad.296962.117
doi: 10.1038/onc.2017.189
61. Zhang C, Shen H, Yang T, et al. A single-cell analysis reveals
51. Ribeiro Moura Brasil Arnaut J, Dos Santos Guimaraes I, tumor heterogeneity and immune environment of acral
Evangelista Dos Santos AC, de Moraes Lino da Silva F, melanoma. Nat Commun. 2022;13(1):7250.
Machado JR, de Melo AC. Molecular landscape of hereditary doi: 10.1038/s41467-022-34877-3
melanoma. Crit Rev Oncol Hematol. 2021;164:103425.
62. Zhao Z, Ding Y, Tran LJ, Chai G, Lin L. Innovative
doi: 10.1016/j.critrevonc.2021.103425
breakthroughs facilitated by single-cell multi-omics:
52. Cakir A, Elcin G, Kilickap S, Gokoz O, Taskiran ZE, Manipulating natural killer cell functionality correlates
Celik I. Phenotypic and genetic features that differ between with a novel subcategory of melanoma cells. Front Immunol.
hereditary and sporadic melanoma: Results of a preliminary 2023;14:1196892.
study from a single center from Turkey. Dermatol Pract
Concept. 2023;13(3):e2023146. doi: 10.3389/fimmu.2023.1196892
63. Tirosh I, Izar B, Prakadan SM, et al. Dissecting the
doi: 10.5826/dpc.1303a146
multicellular ecosystem of metastatic melanoma by single-
53. Zuo L, Weger J, Yang Q, et al. Germline mutations in the cell RNA-seq. Science. 2016;352(6282):189-196.
p16INK4a binding domain of CDK4 in familial melanoma.
Nat Genet. 1996;12(1):97-99. doi: 10.1126/science.aad0501
doi: 10.1038/ng0196-97 64. Li S, Chen L. Multicellular network analysis of
melanoma heterogeneity by scRNA-seq. Am J Transl Res.
54. Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H. 2023;15(4):2345-2369.
Hereditary melanoma: Update on syndromes and
management: Genetics of familial atypical multiple mole 65. Costa GA, de Souza SB, da Silva Teixeira LR, et al. Tumor
melanoma syndrome. J Am Acad Dermatol. 2016;74(3):395- cell cholesterol depletion and V-ATPase inhibition as
407; quiz 408-410. an inhibitory mechanism to prevent cell migration and
invasiveness in melanoma. Biochim Biophys Acta Gen Subj.
doi: 10.1016/j.jaad.2015.08.038 2018;1862(3):684-691.
55. Strashilov S, Yordanov A. Aetiology and pathogenesis of doi: 10.1016/j.bbagen.2017.12.006
cutaneous melanoma: Current concepts and advances. Int J
Mol Sci. 2021;22(12):6395. 66. Kang Z, Wang J, Huang W, Liu J, Yan W. Identification
of transcriptional heterogeneity and construction of a
doi: 10.3390/ijms22126395 prognostic model for melanoma based on single-cell
56. Davis LE, Shalin SC, Tackett AJ. Current state of melanoma and bulk transcriptome analysis. Front Cell Dev Biol.
diagnosis and treatment. Cancer Biol Ther. 2019;20(11): 2022;10:874429.

Volume 9 Issue 1 (2025) 13 doi: 10.36922/ejmo.5809